ENTITY
SMARTSCORE: 2.8/5
QuidelOrtho

QuidelOrtho (QDEL US)

25
Analysis
Health CareUnited States
QuidelOrtho Corporation provides health care services. The Company offers technologies and platforms to benefit customers with expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics offerings.
more
bullishQuidelOrtho
25 Jun 2025 05:00

QuidelOrtho Corporation Is Executing A Billion-Dollar Manufacturing Overhaul; What Is The Expected Revenue Impact?

QuidelOrtho's latest earnings provides insight into the company's performance and strategic direction. For the first quarter of 2025, QuidelOrtho...

Logo
291 Views
Share
bullishQuidelOrtho
28 Mar 2025 05:00

QuidelOrtho Corporation: What Is Their Latest Strategic Shift In Revenue Focus?

QuidelOrtho delivered results in line with their expectations for the full year 2024, closing the year with a total reported revenue of $2.8...

Logo
335 Views
Share
bullishQuidelOrtho
21 Nov 2024 05:00

QuidelOrtho Corporation: Its Diverse Revenue Streams Surge – Discover the Lab Innovations Powering Growth! - Major Drivers

QuidelOrtho's third quarter 2024 financial results reveal a mixed performance, characterized by challenges and opportunities that investors should...

Logo
280 Views
Share
bullishQuidelOrtho
21 Oct 2024 20:00

QuidelOrtho Corporation: These Are The 4 Biggest Factors Driving Our 'Buy' Rating! - Major Drivers

QuidelOrtho's second quarter 2024 financial results were guided by substantial review and restructuring as the new CEO, Brian Blaser, begins to...

Logo
267 Views
Share
bullishQuidelOrtho
13 Jul 2024 18:02

QuidelOrtho Corporation: How Are They Carrying Out The Expansion in Global Markets? - Major Drivers

QuidelOrtho presented its First Quarter 2024 Financial Results, reflecting both strengths and challenges in its operations. The company reported...

Logo
379 Views
Share
x